NewsRamp Psychedelics Podcast

NewsRamp Psychedelics Podcast

Explore the emerging world of psychedelics with the 'NewsRamp Psychedelics Podcast.' This podcast delivers the latest news and insights from NewsRamp.com, focusing on research developments, therapeutic applications, and regulatory changes in the psychedelics field. Stay informed on the groundbreaking advancements in this evolving industry.

Episodes

Optimi Health Corp. Plans Psilocybin Clinical Trial

September 10, 2026 • 1 min
Optimi Health Corp. is set to launch a Phase 2 clinical trial for major depressive disorder using psilocybin-assisted therapy, aiming for potential registration and exclusive ownership of trial results, with funding from current reserves.
Listen
Watch
Mark as Played

Helus Pharma CEO to Speak at Cantor Healthcare Conference

September 4, 2026 • 1 min
Helus Pharma's CEO Michael Halstead will participate in a fireside chat at the Cantor Global Healthcare Conference on September 11, discussing the company's development of serotonergic agonists for mental health conditions. The webcast will be available for replay on the company's investor relations website.
Listen
Watch
Mark as Played

Silo Pharma Explores Ibogaine for TBI & Neuropsychiatric Conditions

May 8, 2026 • 1 min
Silo Pharma Inc. is researching ibogaine-based treatments for traumatic brain injury and related conditions, aiming to address underserved health issues.
Listen
Watch
Mark as Played

Federal Support Boosts Psychedelic Therapeutics

May 3, 2026 • 1 min
Silo Pharma Inc. highlights U.S. federal momentum backing the development of psychedelic-based therapies for mental health and substance use disorders, anticipating innovation in treating conditions such as PTSD and addiction.
Listen
Watch
Mark as Played

Federal Support Boosts Psychedelic Therapeutics

April 29, 2026 • 1 min
Silo Pharma Inc. highlights U.S. federal actions advancing the development of psychedelic-based therapies for mental health and substance use disorders, anticipating innovation in PTSD and addiction treatment.
Listen
Watch
Mark as Played

Optimi Health Corp. Ibogaine Initiative

April 21, 2026 • 1 min
Optimi Health Corp. launches an Ibogaine Initiative to meet demand for pharmaceutical-grade ibogaine and expand its global strategy in psychedelic therapies, aligning with U.S. regulatory changes.
Listen
Watch
Mark as Played

Psychedelic Therapy Companies Embrace White House Executive Order

April 20, 2026 • 2 mins
Helus Pharma(TM) and NRx Pharmaceuticals show support for the Executive Order promoting psychedelic therapies, emphasizing research acceleration and patient access.
Listen
Watch
Mark as Played

Advancements in Stress and Depression Treatments in Europe and U.S.

April 9, 2026 • 1 min
Silo Pharma Inc. secures European patent for stress prevention methods, while NRx Pharmaceuticals works on ketamine labeling and supply in the U.S.
Listen
Watch
Mark as Played

FDA to Review NRX-100 NDA for Depression Treatment

March 16, 2026 • 2 mins
NRx Pharmaceuticals receives FDA approval for NRX-100 ketamine formulation for severe depression treatment based on existing clinical trial data, while NeuroThera Labs Inc. collaborates with Clearmind Medicine Inc. to develop a new non-hallucinogenic therapy for major depressive disorder.
Listen
Watch
Mark as Played

Helus Pharma Appoints Jill Conwell as Chief People Officer

March 12, 2026 • 1 min
Helus Pharma appoints Jill Conwell, a seasoned leader in the life sciences industry, to drive talent strategy and organizational development. Visit the company's newsroom for details.
Listen
Watch
Mark as Played

Transforming Mental Health with IV Ketamine Therapy

March 3, 2026 • 1 min
Dr. Austin Harris of NeuroRelief Ketamine & Infusion Therapy in Los Angeles provides personalized ketamine treatment plans with high success rates, offering continuous support to patients.
Listen
Watch
Mark as Played

Pharma Companies Making Strategic Moves: NRx Pharmaceuticals Debt-Free & Cybin Inc. Transfers to Nasdaq

December 18, 2025 • 2 mins
NRx Pharmaceuticals has eliminated its balance sheet debt through an equity conversion, positioning the company to be debt-free by the end of 2025. Meanwhile, Cybin Inc. is transferring its U.S. stock exchange listing from NYSE American to the Nasdaq Global Market, with common shares set to trade under the ticker symbol 'HELP' starting Jan. 5, 2026. Both companies are focused on advancing innovative mental health treatments and exp...
Listen
Watch
Mark as Played

Cybin Inc. Reports Strong Growth and Progress in Mental Healthcare Innovations

November 13, 2025 • 2 mins
Cybin Inc., a leading neuropsychiatry company, recently announced its successful second-quarter results and highlighted key advancements in its clinical trials and global regulatory approvals. With a focus on revolutionizing mental healthcare, Cybin is actively developing new treatment options for conditions like major depressive disorder and generalized anxiety disorder. George Tziras, the chief business officer, will be presentin...
Listen
Watch
Mark as Played

Revolutionizing Mental Healthcare: Cybin Inc. Conference Call Overview

November 6, 2025 • 1 min
Cybin Inc., a leading neuropsychiatry company, will be hosting a conference call to discuss Q2 results and provide updates on their innovative treatment options for mental health disorders. Founded in 2019, Cybin is focused on developing solutions for major depressive disorder and generalized anxiety disorder, operating in multiple countries including Canada, the U.S., the U.K., and Ireland. For more details, visit Cybin's newsroom...
Listen
Watch
Mark as Played

Revolutionizing Mental Healthcare: Cybin Inc.'s Innovative Drug Development

November 5, 2025 • 2 mins
Cybin Inc., a Phase 3 clinical stage neuropsychiatry company, is set to have their Chief Business Officer speak at the Guggenheim 2nd Annual Healthcare Innovation Conference. The company is dedicated to transforming mental healthcare through the development of novel drugs like CYB003 and CYB004 for major depressive disorder and generalized anxiety disorder, respectively, with the goal of providing effective and lasting treatment op...
Listen
Watch
Mark as Played

Global Psychedelic Week 2025: Uniting the World in Psychedelic Conversation

November 3, 2025 • 3 mins
Global Psychedelic Week 2025 is the first-ever distributed psychedelic conference, gathering 5,000 participants from 100 countries through a hybrid online and in-person model. With over 100 speakers like Rick Doblin and Robin Carhart-Harris, the event aims to spark global conversations on psychedelic science, therapy, and culture. By hosting in-person gatherings worldwide, GPW fosters a truly global movement from the ground up, pro...
Listen
Watch
Mark as Played

Revolutionizing Mental Healthcare: Cybin Inc. to Present at 2025 Milken Institute Future of Health Summit

November 3, 2025 • 1 min
Cybin Inc., a Phase 3 clinical-stage neuropsychiatry company, will have its Chief Medical Officer, Amir Inamdar, speak at the upcoming 2025 Milken Institute Future of Health Summit in Washington, D.C. The company is dedicated to transforming mental healthcare through innovative treatment options like CYB003 for major depressive disorder and CYB004 for generalized anxiety disorder. Operating in multiple countries since its founding ...
Listen
Watch
Mark as Played

Cybin Inc. Announces $175M Direct Offering for Mental Health Treatment Development

October 29, 2025 • 2 mins
Cybin Inc. has revealed a registered direct offering of common shares and warrants, raising over $175 million in gross proceeds. The offering includes renowned investors and aims to support the development of innovative treatment options for mental health conditions like major depressive disorder and generalized anxiety disorder.
Listen
Watch
Mark as Played

Celebrate the Transformative Power of Psychedelics at Global Psychedelic Week 2025

October 27, 2025 • 2 mins
Global Psychedelic Week 2025 offers a diverse program with seven themed days, over 100 events, and 140 speakers from around the world. From scientific discovery to indigenous wisdom, the event explores the evolving landscape of psychedelic research. Visionary voices like Robin Carhart-Harris and Rick Doblin will discuss the fusion of ancient wisdom and modern science. With 5,000 participants from 100 countries, the event aims to un...
Listen
Watch
Mark as Played

Global Psychedelic Week 2025: A Worldwide Exploration of Psychedelic Therapies and Perspectives

October 20, 2025 • 2 mins
Global Psychedelic Week 2025 will feature 130 global speakers and 100 in-person events worldwide, including discussions on psychedelic therapies in crisis zones, evidence-based approaches in psychedelic enterprises, indigenous perspectives, women in psychedelics, and the role of psychedelics in addressing climate change. The conference aims to decentralize the conversation and prioritize inclusivity and community, with early bird r...
Listen
Watch
Mark as Played

Popular Podcasts

    Stuff You Should Know

    Stuff You Should Know

    If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.

    Dateline NBC

    Dateline NBC

    Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations. Follow now to get the latest episodes of Dateline NBC completely free, or subscribe to Dateline Premium for ad-free listening and exclusive bonus content: DatelinePremium.com

    The Breakfast Club

    The Breakfast Club

    The World's Most Dangerous Morning Show, The Breakfast Club, With DJ Envy, Jess Hilarious, And Charlamagne Tha God!

    The Clay Travis and Buck Sexton Show

    The Clay Travis and Buck Sexton Show

    The Clay Travis and Buck Sexton Show. Clay Travis and Buck Sexton tackle the biggest stories in news, politics and current events with intelligence and humor. From the border crisis, to the madness of cancel culture and far-left missteps, Clay and Buck guide listeners through the latest headlines and hot topics with fun and entertaining conversations and opinions.

    Crime Junkie

    Crime Junkie

    Does hearing about a true crime case always leave you scouring the internet for the truth behind the story? Dive into your next mystery with Crime Junkie. Every Monday, join your host Ashley Flowers as she unravels all the details of infamous and underreported true crime cases with her best friend Brit Prawat. From cold cases to missing persons and heroes in our community who seek justice, Crime Junkie is your destination for theories and stories you won’t hear anywhere else. Whether you're a seasoned true crime enthusiast or new to the genre, you'll find yourself on the edge of your seat awaiting a new episode every Monday. If you can never get enough true crime... Congratulations, you’ve found your people. Follow to join a community of Crime Junkies! Crime Junkie is presented by Audiochuck Media Company.

Advertise With Us
Music, radio and podcasts, all free. Listen online or download the iHeart App.

Connect

Explore

iHeart

Live Radio

Podcasts

Artist Radio

Exclusives

News

Features

Events

Contests

Photos

Information

About

Advertise

Blog

Brand Guidelines

Contest Guidelines

Subscription Offers

Jobs

Get the App

Automotive

Home

Wearables

© 2026 iHeartMedia, Inc.

  • Help
  • Privacy Policy
  • Terms of Use
  • AdChoicesAd Choices